Eli Lilly is doubling down on its push to dominate the fast-growing obesity drug market. The pharmaceutical giant announced plans to invest…
Novo Nordisk Shocks Wall Street: Walks Away from $10 Billion Biotech Deal — Smart Move or Massive Mistake?
2 Mins read
Novo Nordisk Drops a Bombshell In a move that has investors scratching their heads, Novo Nordisk walked away from a $10 billion…
